Anna R Giuliano Selected Research

Condylomata Acuminata (Genital Wart)

1/2022	Efficacy, immunogenicity, and safety of a quadrivalent HPV vaccine in men: results of an open-label, long-term extension of a randomised, placebo-controlled, phase 3 trial.
1/2021	Current and future vaccine clinical research with the licensed 2-, 4-, and 9-valent VLP HPV vaccines: What's ongoing, what's needed?
4/2015	Human papillomavirus vaccine intentions among males: a test of the Parallel Processing Model.
12/2012	Quadrivalent human papillomavirus (HPV) types 6, 11, 16, 18 vaccine for the prevention of genital warts in males: profile report. [email protected].
7/2012	HPV-beyond cervical cancer (online resource center).
3/2011	Quadrivalent human papillomavirus (HPV) types 6, 11, 16, 18 vaccine: for the prevention of genital warts in males.
4/2009	Multiple-type human papillomavirus infection in male anogenital sites: prevalence and associated factors.
11/2007	Human papillomavirus vaccination in males.
5/2005	Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anna R Giuliano Research Topics

Disease

58	Neoplasms (Cancer) 10/2022 - 09/2002
52	Papillomavirus Infections 02/2022 - 09/2002
47	Infections 06/2022 - 01/2003
34	Breast Neoplasms (Breast Cancer) 10/2017 - 01/2005
12	Persistent Infection 01/2022 - 04/2002
11	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2021 - 04/2002
9	Condylomata Acuminata (Genital Wart) 01/2022 - 05/2005
7	Oropharyngeal Neoplasms 01/2021 - 06/2010
5	Sexually Transmitted Diseases (Sexually Transmitted Disease) 01/2018 - 10/2004
5	Adenoma (Adenomas) 11/2014 - 09/2002
4	Head and Neck Neoplasms (Head and Neck Cancer) 01/2022 - 08/2008
4	Penile Neoplasms (Penile Cancer) 01/2021 - 11/2016
4	Carcinogenesis 03/2018 - 04/2002
4	Uterine Cervical Dysplasia 12/2016 - 06/2003
3	Warts (Wart) 02/2022 - 02/2012
3	Anus Neoplasms (Anal Cancer) 01/2022 - 10/2011
3	Skin Neoplasms (Skin Cancer) 01/2021 - 11/2008
3	Carcinoma (Carcinomatosis) 01/2021 - 01/2019
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021 - 01/2012
3	Inflammation (Inflammations) 07/2012 - 01/2003
2	Coinfection 06/2022 - 01/2018
2	COVID-19 04/2022 - 03/2022
2	Recurrent respiratory papillomatosis 02/2022 - 01/2021
2	Basal Cell Carcinoma (Rodent Ulcer) 01/2021 - 06/2013
2	Squamous Cell Carcinoma of Head and Neck 01/2019 - 05/2013
2	Vaginal Diseases 01/2019 - 02/2015
2	HIV Infections (HIV Infection) 01/2018 - 02/2015
2	Lymphoma (Lymphomas) 11/2017 - 08/2010
2	Neoplasm Metastasis (Metastasis) 10/2017 - 05/2013
2	Pain (Aches) 01/2016 - 02/2011
2	Colorectal Neoplasms (Colorectal Cancer) 11/2014 - 05/2009
2	Vulvar Neoplasms (Vulvar Cancer) 11/2008 - 08/2008
2	Genital Diseases 10/2007 - 05/2005
1	Erythema Nodosum 01/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021
1	Disease Progression 01/2019
1	Stomach Neoplasms (Stomach Cancer) 01/2019
1	Hepatocellular Carcinoma (Hepatoma) 06/2018
1	Hepatitis B 06/2018
1	Hepatitis 06/2018
1	Thrombosis (Thrombus) 06/2018
1	HIV Seropositivity 11/2017
1	Leukemia 11/2017

Drug/Important Bio-Agent (IBA)

41	VaccinesIBA 01/2022 - 08/2004
34	Papillomavirus Vaccines (HPV Vaccines)IBA 04/2022 - 11/2007
22	Biomarkers (Surrogate Marker)IBA 10/2022 - 01/2005
20	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 06/2008
16	AntibodiesIBA 01/2021 - 05/2009
13	Estrogen ReceptorsIBA 01/2015 - 12/2007
12	Hormones (Hormone)IBA 11/2015 - 04/2007
10	ORALIT (ORS)IBA 01/2018 - 11/2002
8	Progesterone Receptors (Progesterone Receptor)IBA 01/2015 - 01/2013
6	Combined VaccinesIBA 11/2018 - 05/2005
5	Folic Acid (Vitamin M)FDA LinkGeneric 01/2017 - 04/2002
5	Dietary Fiber FDA Link 01/2015 - 09/2002
5	Estrogens (Estrogen)FDA Link 11/2014 - 04/2007
5	AntioxidantsIBA 09/2010 - 01/2003
4	Vitamin A (Retinol)FDA LinkGeneric 01/2017 - 09/2002
4	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 01/2017 - 04/2002
4	Interleukin-6 (Interleukin 6)IBA 08/2014 - 04/2007
3	Viral DNAIBA 01/2021 - 01/2018
3	Secretory Leukocyte Peptidase InhibitorIBA 01/2021 - 05/2013
3	LycopeneIBA 01/2017 - 05/2003
3	Carotenoids (Carotene)IBA 01/2010 - 09/2002
2	insulin receptor-related receptor (IRR)IBA 10/2021 - 12/2015
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 05/2013
2	Oncogene Proteins (Oncogene Protein)IBA 12/2016 - 11/2014
2	Tobacco Smoke Pollution (Passive Smoking)IBA 11/2015 - 05/2008
2	SmokeIBA 11/2015 - 05/2008
2	18 16 11 Types 6 Human Papillomavirus Recombinant Vaccine Quadrivalent (Gardasil)FDA Link 10/2015 - 02/2012
2	Biological ProductsIBA 02/2015 - 08/2008
2	Dietary Fats (Dietary Fat)IBA 01/2015 - 02/2005
2	Methionine (L-Methionine)FDA Link 01/2013 - 04/2002
2	VitaminsIBA 01/2013 - 03/2009
2	Vitamin D FDA LinkGeneric 04/2012 - 05/2004
2	Insulin (Novolin)FDA Link 01/2012 - 04/2007
2	Insulin-Like PeptidesIBA 06/2010 - 07/2005
2	Insulin-Like Growth Factor Binding ProteinsIBA 06/2010 - 07/2005
2	LuteinIBA 03/2009 - 11/2003
2	Beta-CryptoxanthinIBA 03/2009 - 11/2003
2	Ascorbic Acid (Vitamin C)FDA LinkGeneric 03/2009 - 11/2003
2	ZeaxanthinsIBA 03/2009 - 11/2003
2	MicronutrientsIBA 05/2003 - 09/2002
1	2019-nCoV Vaccine mRNA-1273IBA 01/2022
1	COVID-19 VaccinesIBA 01/2022
1	Monoclonal AntibodiesIBA 01/2021
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2021
1	AnticoagulantsIBA 01/2021
1	Fetal Proteins (Fetoprotein)IBA 06/2018
1	Yttrium-90IBA 06/2018
1	AlbuminsIBA 06/2018
1	BilirubinIBA 06/2018
1	ImmunosorbentsIBA 01/2018
1	EnzymesIBA 01/2018

Therapy/Procedure

9	Condoms (Condom) 11/2017 - 10/2004
7	Therapeutics 01/2022 - 01/2015
4	Male Circumcision 02/2014 - 01/2009
2	Fat-Restricted Diet (Diet, Fat Restricted) 02/2005 - 01/2005
1	Radiotherapy 11/2019
1	Chemoradiotherapy 09/2018